Neurol. praxi. 2022;23(5):367-371 | DOI: 10.36290/neu.2022.037

Supraspinal and cognitive-affective components in headaches

MUDr. Pavel Řehulka, Ph.D.
Centrum pro diagnostiku a léčbu bolestí hlavy, I. neurologická klinika FN u sv. Anny a Lékařské fakulty Masarykovy univerzity, Brno

Supraspinal mechanisms are involved in the patophysiology of the most common craniofacial pain disorders (migraine, tension-type headache, myofascial orofacial pain, idiopathic orofacial pain). These diseases are acquired and multifactorial, their developement involves genetic predisposition, hormonal influences and environmental factors (including the psychosocial stress). The exact neurobiological processes of the development of these diseases have not yet been fully elucidated. However, impairment on the both peripheral and central levels of the somatosensory system and the endogenous dysmodulation of nociceptive activity are involved. The bidirectional relationship between psychosocial stress and pain processing has been well documented. Non-pharmacological treatment targeted on this level might be useful and has proven some efficacy.

Keywords: headache, orofacial pain, migraine, tension­‑type headache, sensitisation, stress.

Received: June 13, 2022; Revised: June 26, 2022; Accepted: June 26, 2022; Prepublished online: June 26, 2022; Published: October 6, 2022  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Řehulka P. Supraspinal and cognitive-affective components in headaches. Neurol. praxi. 2022;23(5):367-371. doi: 10.36290/neu.2022.037.
Download citation

References

  1. Baad­‑Hansen L, Leijon G, Svensson P, List T. Comparison of clinical findings and psychosocial factors in patients with atypical odontalgia and temporomandibular disorders. J Orofac Pain. 2008;22(1):7-14. Go to PubMed...
  2. Breslau N. Psychiatric comorbidity in migraine. Cephalalgia. 1998;18(Suppl 22):56-8. Go to original source... Go to PubMed...
  3. Burstein R, Jakubowski M, Garcia­‑Nicas E, et al. Thalamic sensitization transforms localized pain into widespread allodynia. Ann Neurol. 2010;68(1):81-91. Go to original source... Go to PubMed...
  4. Cathcart S, Petkov J, Winefield AH, Lushington K, Rolan P. Central mechanisms of stress­‑induced headache. Cephalalgia. 2010;30(3):285-95. Go to original source... Go to PubMed...
  5. Galvez­‑Sánchez CM, Montoro CI, Moreno­‑Padilla M, et al. Effectiveness of Acceptance and Commitment Therapy in Central Pain Sensitization Syndromes: A Systematic Review. J Clin Med. 2021;10(12):2706. Go to original source... Go to PubMed...
  6. Gil­‑Martínez A, Grande­‑Alonso M, La Touche R, et al. Psychosocial and Somatosensory Factors in Women with Chronic Migraine and Painful Temporomandibular Disorders. Pain Res Manag. 2016;2016:3945673. Go to original source... Go to PubMed...
  7. Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018;38(1):1-211. Go to original source...
  8. Herrero Babiloni A, Nixdorf DR, Moana­‑Filho EJ. Persistent dentoalveolar pain disorder: A putative intraoral chronic overlapping pain condition. Oral, DiS. 2020;26(8):1601-1609. Go to original source... Go to PubMed...
  9. International Classification of Orofacial Pain, 1st edition (ICOP). Cephalalgia. 2020;40(2):129-221. Go to original source...
  10. Jensen RH. Tension­‑Type Headache - The Normal and Most Prevalent Headache. Headache. 2018;58(2):339-345. Go to original source... Go to PubMed...
  11. Jensen K, Tuxen C, Olesen J. Pericranial muscle tenderness and pressure­‑pain threshold in the temporal region during common migraine. Pain. 1988;35(1):65-70.
  12. Lee HJ, Lee JH, Cho EY, Kim SM, Yoon S. Efficacy of psychological treatment for headache disorder: a systematic review and meta­‑analysis. J Headache Pain. 2019;20(1):17. Go to original source... Go to PubMed...
  13. Maarbjerg S, Wolfram F, Heinskou TB, et al. Persistent idiopathic facial pain - a prospective systematic study of clinical characteristics and neuroanatomical findings at 3.0 Tesla MRI. Cephalalgia. 2017;37(13):1231-1240. Go to original source... Go to PubMed...
  14. Martin PR. Behavioral management of migraine headache triggers: learning to cope with triggers. Curr Pain Headache Rep. 2010;14(3):221-7. Go to original source... Go to PubMed...
  15. Miura A, Tu TTH, Shinohara Y, et al. Psychiatric comorbidities in patients with Atypical Odontalgia. J Psychosom Res. 2018;104:35-40. Go to original source... Go to PubMed...
  16. Moseley GL. A pain neuromatrix approach to patients with chronic pain. Man Ther. 2003;8(3):130-40. Go to original source... Go to PubMed...
  17. Nijs J, Paul van Wilgen C, Van Oosterwijck J, van Ittersum M, Meeus M. How to explain central sensitization to patients with 'unexplained' chronic musculoskeletal pain: practice guidelines. Man Ther. 2011;16(5):413-8. Go to original source... Go to PubMed...
  18. Ohrbach R, Michelotti A. The Role of Stress in the Etiology of Oral Parafunction and Myofascial Pain. Oral Maxillofac Surg Clin North Am. 2018;30(3):369-379. Go to original source... Go to PubMed...
  19. Olesen J. Clinical and pathophysiological observations in migraine and tension­‑type headache explained by integration of vascular, supraspinal and myofascial inputs. Pain. 1991;46(2):125-132. Go to original source... Go to PubMed...
  20. Rogante E, Sarubbi S, Lamis DA, et al. Illness Perception and Job Satisfaction in Patients Suffering from Migraine Headaches: Trait Anxiety and Depressive Symptoms as Potential Mediators. Headache. 2019;59(1):46-55. Go to original source... Go to PubMed...
  21. Taiminen T, Kuusalo L, Lehtinen L, et al. Psychiatric (axis I) and personality (axis II) disorders in patients with burning mouth syndrome or atypical facial pain. Scand J Pain. 2011;2(4):155-160. Go to original source... Go to PubMed...
  22. Tietjen GE, Brandes JL, Digre KB, et al. High prevalence of somatic symptoms and depression in women with disabling chronic headache. Neurology. 2007;68(2):134-40. Go to original source... Go to PubMed...
  23. Yunus MB. Editorial review: an update on central sensitivity syndromes and the issues of nosology and psychobiology. Curr Rheumatol Rev. 2015;11(2):70-85. Go to original source... Go to PubMed...
  24. Warren JW, Langenberg P, Clauw DJ. The number of existing functional somatic syndromes (FSSs) is an important risk factor for new, different FSSs. J Psychosom Res. 2013;74(1):12-7. Go to original source... Go to PubMed...
  25. Yunus M, Masi AT, Calabro JJ, Miller KA, Feigenbaum SL. Primary fibromyalgia (fibrositis): clinical study of 50 patients with matched normal controls. Semin Arthritis Rheum. 1981;11(1):151-71. Go to original source... Go to PubMed...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.